Skip to main content
. Author manuscript; available in PMC: 2017 Nov 28.
Published in final edited form as: J Steroid Biochem Mol Biol. 2016 Aug 9;165(Pt B):356–362. doi: 10.1016/j.jsbmb.2016.08.002

Figure 4. Inhibition of CMV replication by the VDR agonist EB-1089.

Figure 4

100 % confluent HFF were seeded in 24-wells, infected with CMV strain AD169 and treated with 1 nM Calcitriol and two-fold dilution series of EB-1089 or Ganciclovir starting with 200 nM or 200 µM, respectively. All experiments were done in triplicates (arrow bars show SEM). The dashed line indicates 50 % inhibition of CMV replication.